BioGeometry Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$14.9M
- Investors
-
12
BioGeometry General Information
Description
Developer of a biologics design platform designed for protein design and optimization. The company's technology utilizes geometric deep learning and flow matching to enable epitope-specific antibody generation, de novo design, humanization, affinity analysis, and druglikeness analysis, providing pharmaceutical companies with a closed-loop system to accelerate large-molecule drug discovery and reduce research costs.
Contact Information
Website
www.biogeom.comCorporate Office
- Room 604, Building A, Rongke Information Center
- Number. 2 South Road of the Chinese Academy of Sciences, Haidian District
- Beijing, 100190
- China
Corporate Office
- Room 604, Building A, Rongke Information Center
- Number. 2 South Road of the Chinese Academy of Sciences, Haidian District
- Beijing, 100190
- China
BioGeometry Timeline
BioGeometry Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A1) | 28-Oct-2026 | $14.9M | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series A) | 09-Jun-2026 | Completed | Generating Revenue | |||
| 3. Early Stage VC | Cancelled | Generating Revenue | ||||
| 2. Early Stage VC | 19-Jun-2024 | $10M | Completed | Generating Revenue | ||
| 1. Seed Round | 21-Sep-2022 | $10M | $10M | Completed | Startup |
BioGeometry Signals
BioGeometry Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CDB Venture | Venture Capital | Minority | ||
| China Life Investment Management Company | Asset Manager | Minority | ||
| Shanghai Healthcare Capital | PE/Buyout | Minority | ||
| Shanghai Rui Investment Fund Management | Asset Manager | Minority | ||
| Beijing Xinglian Zhaoji Private Equity Fund Management | Venture Capital | Minority |
BioGeometry FAQs
-
When was BioGeometry founded?
BioGeometry was founded in 2021.
-
Where is BioGeometry headquartered?
BioGeometry is headquartered in Beijing, China.
-
What is the size of BioGeometry?
BioGeometry has 30 total employees.
-
What industry is BioGeometry in?
BioGeometry’s primary industry is Discovery Tools (Healthcare).
-
Is BioGeometry a private or public company?
BioGeometry is a Private company.
-
What is BioGeometry’s current revenue?
The current revenue for BioGeometry is .
-
How much funding has BioGeometry raised over time?
BioGeometry has raised $24.9M.
-
Who are BioGeometry’s investors?
CDB Venture, China Life Investment Management Company, Shanghai Healthcare Capital, Shanghai Rui Investment Fund Management, and Beijing Xinglian Zhaoji Private Equity Fund Management are 5 of 12 investors who have invested in BioGeometry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process